Brugada Syndrome Panel

Casandra

Casandra Test Code PG92512Version 1 (DRAFT)

Performing Lab

Lab Prevention GeneticsLab Test ID 10329CPT Code 81479

Brugada Syndrome Panel

Clinical Use

Use

This test is designed for individuals with relevant features who have a clinical or suspected diagnosis of Brugada syndrome. It also serves those who have a family member with Brugada syndrome but without previous genetic testing or individuals without access to specific variant information for a family member who has genetically-confirmed Brugada syndrome.

Special Instructions

This test offers STAT testing that delivers results within 7 to 16 days with an additional surcharge. It also supports exome-wide CNV analysis as an add-on when ordered with PGxome-based or custom panels, but not available for PG-Select panels, Sanger sequencing, and other test methods.

Limitations

Tests were developed following CLIA and CAP regulations, yet have not been cleared or approved by the US FDA. Test results should be interpreted in the context of clinical information provided as they are dependent on the quality of such information.

Test Details

New York Approved

Methodology

NGS (WES)

Biomarkers

This panel uses Next-Generation Sequencing (NGS) on the Exome Platform and includes CNV analysis to detect genetic variations associated with Brugada Syndrome.

NGS Sequencing with CNV • WES